Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 广东广康生化科技股份有限公司是专业从事农药原药、中间体、制剂的研发、生产和销售的国家高新技术企业。自2003年成立以来，公司经过十多年发展，建设了先进的产品研发、工程、生产、质量、成本精益管理体系，具备了安全、环保、健康管理的能力，是广东省内颇具规模的国家定点农用化学品生产企业。是中国农药发展与应用协会理事单位、中国石油化工优秀民营企业、中国农药工业协会AA级信用企业、广东省创新型企业、广东省知识产权贯标认证企业。现已建立了严格、规范的生产管理体系，通过了GB/T19001-2016/ISO9001:2015质量管理体系认证、GB/T45001-2020/ISO45001:2018职业健康安全管理体系认证和GB/T24001-2016/ISO14001:2015环境管理体系认证，公司现已发展为广东省内规模较大的农药生产企业之一。
Main Business 专业从事农药原药、中间体、制剂的研发、生产和销售。
Legal Representative 蔡丹群
Top Executives
董事长：蔡丹群
董事：蔡绍欣,王世银,林阳涵
独立董事：张志祥,黄志威,彭文平
Top 5 Shareholder
Shareholder name Nature Holding Date
蔡丹群限售股34.89%30/09/2024
蔡绍欣限售股21.19%30/09/2024
英德众兴投资管理有限公司限售股6.76%30/09/2024
深圳市前海瑞宏凯银资产管理有限公司－共青城瑞宏凯银壹号股权投资基金合伙企业（有限合伙）流通A股5.68%30/09/2024
深圳市华拓私募股权投资基金管理有限公司－共青城华拓至盈贰号投资合伙企业（有限合伙）流通A股1.82%30/09/2024
Company Secretary 陈海霞
Solicitors 北京市君合律师事务所
Auditors 信永中和会计师事务所（特殊普通合伙）
Tel No 020-38319242
Fax No 0763-2551846
Website www.greatchem.com.cn
Email ir@greatchem.com.cn
Company Address
Register: 广东省英德市农用化工产业链专用基地（英德市沙口镇红丰管理区）
Office: 广东省广州市天河区高普路97号A-B座6楼（601-603房）
Listing Date 27/06/2023
Shares Capital
Shares Capital: 74,000,000
Total A Share: 74,000,000
Listed A Share: 27,500,000
Non-tradable A Share: 46,500,000
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.460
DPS(RMB)* ¥ 0.675
NBV Per Share(RMB)* ¥ 17.373
Market Capitalization(RMB) 0.700B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.